Tauvid is a diagnostic medicine that is used during brain scans in adults with cognitive impairment (memory and thinking problems) who are being evaluated for Alzheimer’s disease. Tauvid is used during a type of scan called positron-emission tomography (PET) to help doctors assess the presence and distribution in the brain of abnormal forms of the tau protein, which are present in the brain of people with Alzheimer’s disease. Tauvid contains the active substance flortaucipir (18F).
Therapeutic Indication
### Therapeutic indication This medicinal product is for diagnostic use only. Flortaucipir (18F) is a radiopharmaceutical indicated for positron emission tomography (PET) imaging of the brain to assess the neocortical distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD). Flortaucipir (18F) is an adjunct to clinical and other diagnostic evaluations. For limitations of use, see sections 4.4 and 5.1.
Therapeutic Area (MeSH)
ATC Code
V09AX07
ATC Item
flortaucipir (18F)
Pharmacotherapeutic Group
Diagnostic radiopharmaceuticals
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Flortaucipir (18F) | N/A | Flortaucipir F-18 |
EMA Name
Tauvid
Medicine Name
Tauvid
Aliases
N/ANo risk management plan link.
